Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-044909
Filing Date
2015-05-20
Accepted
2015-05-20 16:13:34
Documents
2
Period of Report
2015-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1562
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3426
  Complete submission text file 0001209191-15-044909.txt   6673
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Issuer) CIK: 0000849146 (see all company filings)

EIN.: 841097796 | State of Incorp.: CO | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIFEVANTAGE CORPORATION 9785 SOUTH MONROE ST. SUITE 300 SANDY UT 84070
Business Address
Jensen Darren Jay (Reporting) CIK: 0001642848 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35647 | Film No.: 15879774